We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

168 hedge funds and large institutions have $2.04B invested in Medicines Co in 2013 Q2 according to their latest regulatory filings, with 168 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $15.4M

Holders
168
Holders Change
+168
Holders Change %
–
% of All Funds
5.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
168
Increased
–
Reduced
–
Closed
–
Calls
$23.6M
Puts
$15.4M
Net Calls
+$8.18M
Net Calls Change
+$8.18M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$16.3M +$17.7M +529,447 New
HSA
27
Hussman Strategic Advisors
Maryland
$15.8M +$17.2M +513,000 New
Principal Financial Group
28
Principal Financial Group
Iowa
$15.4M +$16.7M +500,366 New
TA
29
Teachers Advisors
New York
$13.9M +$15.1M +451,625 New
WC
30
Wexford Capital
Florida
$11.3M +$12.3M +368,480 New
PI
31
Putnam Investments
Massachusetts
$11.1M +$12.1M +361,858 New
Public Employees Retirement Association of Colorado
32
Public Employees Retirement Association of Colorado
Colorado
$11M +$11.9M +356,341 New
PWPCM
33
Perella Weinberg Partners Capital Management
New York
$9.68M +$10.5M +314,542 New
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$9.57M +$10.4M +311,180 New
TCIM
35
TIAA CREF Investment Management
New York
$9.36M +$10.2M +304,145 New
BB
36
BB Biotech
Switzerland
$9.32M +$10.1M +302,993 New
PAM
37
Panagora Asset Management
Massachusetts
$9.18M +$9.98M +298,360 New
CCM
38
Cadence Capital Management
Massachusetts
$9.14M +$9.95M +297,299 New
Deutsche Bank
39
Deutsche Bank
Germany
$8.67M +$9.43M +281,831 New
SCA
40
SAC Capital Advisors
Connecticut
$8.64M +$9.4M +280,876 New
SGA
41
Sector Gamma AS
Norway
$8.45M +$9.19M +274,750 New
Norges Bank
42
Norges Bank
Norway
$7.09M +$7.72M +230,648 New
Geode Capital Management
43
Geode Capital Management
Massachusetts
$7.01M +$7.63M +227,975 New
QBFM
44
QS Batterymarch Financial Management
New York
$6.76M +$7.35M +219,803 New
Ameriprise
45
Ameriprise
Minnesota
$6.43M +$6.99M +209,034 New
PAMU
46
Pictet Asset Management (UK)
United Kingdom
$6.07M +$6.6M +197,300 New
Allianz Asset Management
47
Allianz Asset Management
Germany
$5.95M +$6.47M +193,425 New
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$5.9M +$6.41M +191,701 New
Morgan Stanley
49
Morgan Stanley
New York
$5.87M +$6.39M +190,896 New
BIM
50
BlackRock Investment Management
Delaware
$5.47M +$5.94M +177,691 New
1
2
3 4 5

MDCO Hedge Fund Activity: Q2 2013 in Review

168 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2013, worth a combined $2.04B.

Buyers outnumbered sellers: 168 funds opened new MDCO positions and 0 closed out — a net gain of 168 holders — while 0 added to existing stakes and 0 trimmed.

  • 168 institutional investors held Medicines Co (MDCO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.04B of Medicines Co stock for Q2 2013.
  • 168 funds opened new Medicines Co positions in Q2 2013 and 0 closed out, a net change of +168 holders.

Based on aggregated 13F filings for Q2 2013.